普埃拉林通过调节新陈代谢和肠道微生物群来缓解大肠炎小鼠的炎症和病理损伤
Yixin Zou1, Wenjiao Ding1, You Wu1
1State Key Laboratory of Food Science and Resources, School of Food Science, Nanchang University, Nanchang, China.
Frontiers in microbiology
|November 1, 2023
概括
普埃拉林通过恢复肠道微生物群平衡和新陈代谢来显示性结肠炎 (UC) 的治疗潜力. 它通过调节细菌群和代谢途径来减少炎症并改善肠道健康.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物群失调和代谢障碍与性结肠炎 (UC) 有关.
- 性结肠炎是一种慢性炎症性肠病,影响结肠.
研究的目的:
- 在性结肠炎的小鼠模型中研究皮亚林对肠道微生物群和代谢途径的治疗作用.
- 阐明皮亚林在UC中的作用背后的机制.
主要方法:
- 网络药理学被用来确定puerarin作为潜在的治疗剂.
- 建立了一个由硫酸 (DSS) 诱导的性结肠炎 (UC) 的小鼠模型.
- 分析了肠道微生物组成,炎症标志物 (IL-1β,IL-6,TNF-α) 和代谢途径.
主要成果:
- 普埃拉林治疗改善了密室变形,并减少了小鼠的炎症透.
- 普埃拉林调节肠道微生物群,减少有害细菌 (例如,Alistipes,P.copri) 和增加有益的细菌 (例如,Desulfovibrionacea).
- 普埃拉林缓解了新陈代谢障碍,特别是在 Tryptophan 代谢中,并增加了关素水平.
结论:
- 普埃拉林在小鼠的性结肠炎上表现出显著的治疗作用.
- 这些效应部分通过恢复肠道微生物群的组成和功能来调节.
- 普埃拉林使肠道微生物代谢正常化,为UC提供了潜在的治疗策略.
相关概念视频
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


